# Clevidipine in Neurocritical Patients

> **NCT05168059** · — · COMPLETED · sponsor: **Hospital de Cruces** · enrollment: 33 (actual)

## Conditions studied

- High Blood Pressure

## Interventions

- **DRUG:** Clevidipine 0.5 MG/ML Intravenous Emulsion

## Key facts

- **NCT ID:** NCT05168059
- **Lead sponsor:** Hospital de Cruces
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-01
- **Primary completion:** 2018-12-31
- **Final completion:** 2019-09-01
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2021-12-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05168059

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05168059, "Clevidipine in Neurocritical Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05168059. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*